Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Prostatic nodules detected by digital rectal examination, any level of PSA; 2. Abnormal images detected by ultrasound, CT or MRI, any level of PSA; 3. PSA>10ng/ml, any level of f/tPSA and PSAD; 4. PSA: 4-10ng/ml, but abnormal value of f/tPSA and PSAD.
Exclusion criteria
Exclusion criteria: 1. In acute infection period or stage of fervescence; 2. Hypertensive crisis; 3. Decompensated heart failure; 4. Some disease with severe bleeding tendency; 5. Fluctuating blood glucose levels with diabetes; 6. Serious internal and external hemorrhoids, perianal or rectal lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prostate volume;prostate-specific antigen;digital rectal examination findings;imaging (ultrasound, CT or MRI) findings;the family history of prostate cancer;mean artery pressure (MAP);heart rate (HR);respiratory rate (RR);oxygen saturation (SPO2);The pain degree of patients;The consuming time of the every step of the operation;The blood loss;the occurrence rate low blood pressure;the occurrence rate of slow heart rate;the occurrence rate respiratory depression;the occurrence rate infection;the occurrence rate perineal bleeding;the occurrence rate urethral bleeding;the occurrence rate hematospermia;the occurrence rate retention of urine;the occurrence rate dysuresia;The positive detectable rate of prostatic carcinoma;the Gleason score;the duration of hospital stays;the total hospitalization expenses; | — |
Countries
China
Contacts
Xiangya Hospital of Central South University